Susanna High

Susanna G.
High is currently the Chief Operating Officer at Dyne Therapeutics, Inc. She previously worked as the Chief Operating Officer at bluebird bio, Inc. from 2016 to 2019.
Prior to that, she was the SVP-Strategy & Business Integration at Alnylam Pharmaceuticals, Inc. from 2015 to 2016.
From 2001 to 2007, she worked as the Director-Corporate Strategy at Millennium Pharmaceuticals, Inc. Susanna's earliest job was as a Management Consultant at Accenture LLC from 1996 to 2001.
She received a graduate degree from the University of Bocconi and an MBA from MIT Sloan School of Management in 1996.